Moderna flu vaccine shows superior results in phase 3 study
Pharma Times
JULY 1, 2025
Most adverse reactions were mild, with injection site pain the most common local effect. Fatigue, headache and myalgia were the most reported systemic reactions. There were no notable differences between groups in terms of unsolicited or serious adverse events. Safety results were consistent with earlier phase 3 data.
Let's personalize your content